Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors
Authors:
- Kui ChengKCKui Cheng
- Xiaohui WangXiaohui Wang
- Hang YinHang Yin
- 1 October 2012
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 20 (20) , 6073-6079
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Small-Molecule Inhibitors of the TLR3/dsRNA ComplexJournal of the American Chemical Society, 2011
- Toll‐like receptor 4 in CNS pathologiesJournal of Neurochemistry, 2010
- Selection, Preparation, and Evaluation of Small-Molecule Inhibitors of Toll-Like Receptor 4ACS Medicinal Chemistry Letters, 2010
- Microglial Activation by Citrobacter koseri Is Mediated by TLR4- and MyD88-Dependent PathwaysThe Journal of Immunology, 2009
- Substituted aryl malonamates as new serine β-lactamase substrates: Structure–activity studiesBioorganic & Medicinal Chemistry, 2009
- Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia CellsMolecules, 2009
- Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis modelBritish Journal of Pharmacology, 2009
- Pathogen Recognition and Innate ImmunityCell, 2006
- The role of inflammation in CNS injury and diseaseBritish Journal of Pharmacology, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005